Select one or more of these to search for research publications pertaining to these substances. Select multiple substances by holding the Control key while clicking.
Specify authors to search for.
Specify search keywords.
Specify a date range to search within.

search in publications
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

substances ?
authors ?
keywords ?
date ?
 from
 to

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CVO - Onderzoek, Training & Advies  .  Montalbaendreef 2, 3562 LC Utrecht  .  T +31 30 2381 495  .  E cvo-info@drugresearch.nl  

nederlandse versie

Evaluation of the Governmental Strategy and Action Plan 2010-2014 of Luxembourg regarding the fight against drugs and addictions

FranzTrautman, Richard Braam

Trimbos-Institute, 2014
isbn 9789052537573

order

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 

Summary On request of the Luxembourg Ministry of Health, the Trimbos Institute has conducted an evaluation of the Governmental Strategy and Action Plan 2010-2014 of Luxembourg regarding the fight against drugs and addictions. This evaluation report starts with a summary, followed by chapter 2 with a short description of the objectives, the structure and the priorities of the Strategy and the Action Plan. Based on this we identified the key questions for the evaluation.

Chapter 3 describes the project methodology and activities. In chapter 4 we present an assessment of what has been achieved in the period covered
by the strategy and action plan based on a survey (questionnaires) and a face-to-face interview round among stakeholders. In Annex 4 we summarize these achievements in a balance sheet. Chapter 5 describes the results of a SWOT analysis assessing the Strengths, Weaknesses, Opportunities and Threats of the Drug Strategy and Action Plan based on the findings from the questionnaires and the face-to-face interviews with stakeholders. Chapter 6 follows with a discussion of findings based among others on the focus group with key stakeholders. Finally, in chapter 7 we present recommendations for the new Drug Strategy and Action Plan.

 

back to top